Access & Support
Access and Reimbursement Help
Co-pay assistance, benefit investigations, and more through Nabriva RX Connect
Nabriva RX Connect reimbursement specialists can assist healthcare providers with questions regarding access and reimbursement for Nabriva products.
Available for eligible patients with commercial insurance. Patients pay no more than $50 for each prescription of XENLETA tablets through designated specialty pharmacies.Access Copay Assistance
Patient Assistance Program (PAP)
Available for eligible patients. Nabriva Therapeutics US, Inc. will provide financial assistance (through in-kind product donations) to uninsured or underinsured patients who meet specific income requirements.
Designated specialty pharmacies or a Nabriva RX Connect reimbursement specialist will contact the patient’s insurance company to collect information regarding the patient’s coverage and benefits for XENLETA.
Prior Authorization Support
Designated specialty pharmacies or a Nabriva RX Connect reimbursement specialist will contact the patient’s insurance company to collect information on whether a prior authorization is required, and any specific requirements. They may also help the healthcare provider follow up on the status and outcome of a healthcare provider–submitted prior authorization request for XENLETA.
Specialty Retail and Specialty
A Nabriva RX Connect reimbursement specialist will assist the healthcare provider in identifying a designated specialty pharmacy to dispense XENLETA tablets. For a pharmacy near you, call Nabriva RX Connect at 1-855-5NABRIVA (Option 3) for pharmacy information.
Nabriva RX Connect
for more information
Access and Reimbursement Materials
Additional access support resources available to download:
Register for Updates